Updates are available Correction dated 2020-04-23
Click to view Correction: https://doi.org/10.1007/s00404-020-05544-z
-
Authors
Palacios, Santiago
Colli, Enrico
Regidor, Pedro-Antonio
- License Information
-
More Information
Article History
Received: 8 July 2019
Accepted: 15 October 2019
First Online: 14 November 2019
Change Date: 23 April 2020
Change Type: Correction
Change Details: The article A multicenter, double-blind, randomized trial on the bleeding profle of a drospirenone-only pill 4��mg over nine cycles in comparison with desogestrel 0.075��mg, written by Santiago Palacios, Enrico Colli and Pedro-Antonio Regidor, was originally published Online First without Open Access.
Compliance with ethical standards
:
: Santiago Palacios is a consultant to Pfizer, Amgen, MSD, Gynea, Procare Health, Bayer, Sérélys Shinogi, Exeltis, Abbott and Gedeon Richter. Enrico Colli and Pedro Antonio Regidor are employees of Exeltis.
: All participants gave their written informed consent for participation in the clinical trial after obtention of the correspondent ethical committee approval.
: For each of the investigational centers an ethical approval was obtained (see appendix 1). The overall approval for the trial with the leading ethical committee was given the 13.07.2012 by the Landesamt für Gesundheit und Soziales Berlin, Geschäftstelle der Ethik Kommission des Landes Berlin, number 11/0606 EK.
